EUVIMEDEUVIMED entdecken
Crossref

Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging

Mylène Richard iD, Soizic Martin Aubert, Caroline Denis, Steven Dubois, Hervé Nozach, Charles Truillet iD, Bertrand Kuhnast iD

Bioconjugate Chemistry · 2023

DOI: 10.1021/acs.bioconjchem.3c00440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2023. Verfasst von Mylène Richard und 6 weiteren Autor:innen. Beteiligte Einrichtung: CEA, CNRS, Inserm, BioMaps, SHFJ, Paris-Saclay University, Orsay 91401, France. Hauptthemen laut MEDLINE: Copper Radioisotopes, Fluorine Radioisotopes, Radioisotopes, Zirconium. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomolecules labeled with positron-emitting radionuclides like fluorine-18 or radiometals like copper-64 and zirconium-89 are increasingly employed in nuclear medicine for diagnosis purposes. Given the fragility and complexity of these compounds, their labeling requires mild conditions. Besides, it is essential to develop methods inducing minimal modification of the tertiary structure, as it is fundamental for the biological activity of such complex entities. Given these requirements, disulfide rebridging represents a promising possibility since it allows protein modification as well as conservation of the tertiary structure. In this context, we have developed an original radiofluorinated dibromopyridazine dione prosthetic group for labeling of disulfide-containing biomolecules via rebridging. We employed it to radiolabel octreotide, a somatostatin analogue, and to radiolabel fragment antigen binding (Fab) targeting programmed death-ligand 1 (PD-L1), whose properties were then evaluated in vitro and in vivo by positron emission tomography (PET) imaging. We next extended our strategy to the radiolabeling of cetuximab, a monoclonal antibody, with various radiometals commonly used in PET imaging (zirconium-89, copper-64) by developing various rebridging molecules bearing the appropriate chelators. The stabilities of the radiolabeled antibody conjugates were assessed in biological conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Copper RadioisotopesFluorine RadioisotopesRadioisotopesZirconiumPositron-Emission TomographyRadiopharmaceuticals

Substanzen

Zirconium-89Fluorine-18Copper-64Copper RadioisotopesFluorine RadioisotopesRadiopharmaceuticalsRadioisotopesZirconium

Autor:innen und Institutionen

  • CEA, CNRS, Inserm, BioMaps, SHFJ, Paris-Saclay University, Orsay 91401, France.
  • CEA, INRAE, Medicines and Healthcare Technologies Department, SIMoS, Paris-Saclay University, Gif-sur-Yvette 91191, France.

ORCID-Profile: Mylène Richard, Charles Truillet, Bertrand Kuhnast

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Richard, M., Martin Aubert, S., Denis, C., Dubois, S., Nozach, H., Truillet, C., & Kuhnast, B. (2023). Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.3c00440

Vancouver

Richard M, Martin Aubert S, Denis C, Dubois S, Nozach H, Truillet C, et al. Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging. Bioconjugate Chemistry. 2023. doi:10.1021/acs.bioconjchem.3c00440

BibTeX
@article{Richard2023,
  author = {Richard, Mylène and Martin Aubert, Soizic and Denis, Caroline and Dubois, Steven and Nozach, Hervé and Truillet, Charles and Kuhnast, Bertrand},
  title = {Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging},
  journal = {Bioconjugate Chemistry},
  year = {2023},
  doi = {10.1021/acs.bioconjchem.3c00440}
}
Kostenlos starten →